How much does life sciences insurance cost by company revenue?

All ranges below are Texas-based life-sciences operators carrying programs designed to satisfy sponsor MSA or hospital purchase contract requirements. The ranges assume a clean five-year claims history, current regulatory compliance (FDA registration for 503Bs, USP 797/800 for compounders), and A.M. Best A- VII or better carrier rating.

Within-range variation reflects product class (sterile injectables, biologics, oncology drive the upper end; oral solid dose, simple medical devices drive the lower end), facility complexity (cGMP facilities cost more than standard pharmacy facilities), and prior claims history.

$5M revenue: $25,000 to $50,000 annual program (CGL/products tower, WC, auto, umbrella, basic property). Product class drives variation.

$20M revenue: $55,000 to $140,000 (broader products tower, $5M-$10M, professional liability if CDMO scope, cyber).

$50M revenue: $120,000 to $300,000 (full program with $10M+ products, $5M+ recall, cyber, professional liability, D&O if applicable).

$100M+ revenue: $250,000 to $750,000+ (multi-layer products tower, dedicated recall, environmental, full international package).

$5M revenue: $20,000 to $40,000 (professional liability/E&O is the dominant cost; smaller property/casualty exposure).

$20M revenue: $50,000 to $110,000 (broader E&O, $3M-$10M cyber, clinical trial liability where applicable).

$50M revenue: $100,000 to $250,000 (larger E&O tower, full cyber program, international package for global trials).

$5M revenue: $30,000 to $65,000 (products is the dominant cost; severity by device class).

$20M revenue: $80,000 to $200,000 (Class II/III devices drive upper end; GPO supplier compliance lifts the floor).

$50M revenue: $180,000 to $450,000 (full products tower, dedicated recall, cyber, professional liability for service/installation).

Pre-revenue clinical-stage: $35,000 to $120,000 (D&O dominates; clinical trial liability where applicable; cyber).

Post-IPO clinical-stage: $150,000 to $500,000+ (larger D&O tower, securities-class-action exposure, full cyber).

$2M revenue: $8,000 to $20,000 (druggist PL primary; basic products; cyber/HIPAA).

$10M revenue: $20,000 to $50,000 (higher druggist PL, accreditation-driven coverage).

GLP-1 compounders: add 50%-150% to the above ranges — market conditions remain elevated.

$10M revenue: $75,000 to $200,000 (FDA-registered cGMP environment; $5M-$10M products; cGMP property; recall).

$50M revenue: $250,000 to $600,000+ (full hospital purchase contract program with all GPO requirements).

GLP-1 503Bs: market conditions vary widely and may not be commercially placeable at standard ranges.

$5M revenue: $20,000 to $45,000 (professional liability, cyber/HIPAA, property, basic GL).

$25M revenue: $60,000 to $150,000 (larger cyber for PHI scale, professional liability sized to volume).

$50M+ revenue: $130,000 to $325,000 (full enterprise program, ransomware coverage, regulatory defense).

These ranges are directional, not quotes. Actual premium depends on the specific operator's claims history, facility profile, product mix, sponsor and hospital contract obligations, jurisdictional exposure, and the specific market(s) underwriting the program. Variation of 50% above or below the range is not uncommon for operators with unusual risk profiles.

For an actual quote, the Free Insurance Requirements Analyzer at lifesciencesliability.com produces a per-operator review aligned to your specific contract obligations and program structure.